FORM 3 UNITED STATES SECURITIES AND EXCHANGE...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC...
STAMFORD, Conn., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc.Ā (Nasdaq:LOXO), a biopharmaceutical...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may...
First treatment with a tumor-agnostic indication at the time of initial FDA approval75% overall response rate...
By Josh Beckerman An oncology drug developed by Loxo Oncology Inc. (LOXO) and Bayer AG (BAYRY, BAYN.XE) has received accelerated approval from the...
Table of Contents UNITED STATES SECURITIES AND...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.